Chemical Research in Chinese Universities ›› 2019, Vol. 35 ›› Issue (1): 53-59.doi: 10.1007/s40242-019-8284-5

• Articles • Previous Articles     Next Articles

Spectral Study on the Interactions Among Cu(II), Doxorubicin and CopC

SONG Yunxi1, SONG Zhen2, YANG Binsheng1   

  1. 1. Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Institute of Molecular Science, Shanxi University, Taiyuan 030006, P. R. China;
    2. Department of Chemistry, Taiyuan Normal University, Jinzhong 030619, P. R. China
  • Received:2018-09-10 Revised:2018-10-07 Online:2019-02-01 Published:2018-11-26
  • Contact: YANG Binsheng E-mail:yangbs@sxu.edu.cn
  • Supported by:
    Supported by the National Natural Science Foundation of China (Nos.21571117, 21701121).

Abstract: Interactions among Cu (Ⅱ), doxorubicin and copper operon C (CopC) have been investigated in detail by means of fluorescence, UV-Vis, IR spectra, isothermal titration calorimetry (ITC) and molecular docking in Tris-HCl buffer (50 mmol/L, pH=7.4, 25℃). The results suggest that Cu (Ⅱ)-doxorubicin is formed in a Cu (Ⅱ) to doxorubicin molar ratio of 1:2, and the conditional stability constant, K [Cu (Ⅱ)-doxorubicin] is 1.90×109 L2/mol2, CopC and doxorubicin can form a 1:1 complex, the conditional stability constant is greater than 105 L/mol. Binding of doxorubicin causes a conformational change in CopC with the reduction of β-sheet and increase of random coil, and the stability of CopC is decreased. Cu (Ⅱ), doxorubicin and CopC can form a CopC-Cu (Ⅱ)-doxorubicin ternary complex. The formation of CopC-Cu (Ⅱ)-doxorubicin reduced greatly the reduction rate of Cu (Ⅱ) by ascorbate (Vc), i.e., the binding of doxorubicin affects the action of CopC as redox switch.

Key words: Doxorubicin, Copper operon C (CopC), Cu (II) interaction